Jennifer Pietenpol Archives
New space bolsters infectious disease and immunology discovery
Jul. 9, 2020—The Vanderbilt Institute for Infection, Immunology and Inflammation (VI4) recently moved into its new research and administrative home.
State cancer plan has robust input and commitment from Vanderbilt-Ingram Cancer Center
May. 21, 2020—More than a dozen representatives of Vanderbilt University Medical Center helped plan and made a commitment to help carry out the strategy for how Tennessee will prevent cancer and minimize its burden on state residents.
VUMC research ramps up in COVID-19 transition
May. 21, 2020—As Nashville cautiously begins to emerge from its two-month-long COVID-19 Safer at Home response, so too are the labs and facilities at Vanderbilt University Medical Center.
Triple-negative breast cancer drug therapy shows promise
Mar. 12, 2020—Researchers from Vanderbilt-Ingram Cancer Center (VICC) discovered a role for MYCN in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further clinical investigation.
Breast cancer study may help predict treatment response
Feb. 27, 2020—Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat.
Pietenpol, Wilson land Komen cancer research support
Oct. 24, 2019—Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.
Grant strengthens breast cancer research efforts
Aug. 22, 2019—Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.
A critical factor for wound healing
Jul. 16, 2019—Vanderbilt-Ingram Cancer Center scientists have discovered a role for a tumor suppressor protein in skin wound healing.
Patient-centered design to be focus of StrategyShare19
Apr. 18, 2019—StrategyShare19, an annual, interactive event at Vanderbilt University Medical Center to showcase innovations and initiatives to advance the Medical Center’s Strategic Directions, is focusing this year on Design for Patients and Families — one of the four Strategic Directions — and efforts to enhance patient, clinician and staff experiences.
Cancer Center investigators awarded Komen grants
Oct. 11, 2018—Four Vanderbilt-Ingram Cancer Center (VICC) investigators have received financial support from Susan G. Komen for breast cancer research.
Vanderbilt thinkers come together for StrategyShare18
Jun. 28, 2018—Jun. 28, 2018—A multidisciplinary cross section of the Vanderbilt University Medical Center and Vanderbilt University community gathered Tuesday during StrategyShare18, an interactive half-day event to share ideas, invite collaborations and spur new initiatives.
Directorships honor VUMC’s critical missions
Jan. 25, 2018—Vanderbilt University Medical Center (VUMC) on Monday held its first Directorship Celebration to honor and support eight of its leaders in clinical care, research, education and administration.
